Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Eph Receptor A2 ELISA Kit (AC2916)
Cat.#: ASET-1505
Specifications
Description Human Eph Receptor A2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Eph Receptor A2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.026 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2255 Mouse Semaphorin 7a ELISA Kit (AC3666) Quantitative inquiry ASET-2336 Rat Synaptophysin ELISA Kit (AC3747) Quantitative inquiry ASET-2155 Rat MAdCAM1 ELISA Kit (AC3566) Quantitative inquiry ASET-1514 Human Slit3 ELISA Kit (AC2925) Quantitative inquiry ASET-1023 Human ACTH ELISA Kit (AC2434) Quantitative inquiry ASET-1141 Human Dio3 ELISA Kit (AC2552) Quantitative inquiry ASET-1894 Human FGFR4 ELISA Kit (AC3305) Quantitative inquiry ASET-2069 Mouse Neurotensin ELISA Kit (AC3480) Quantitative inquiry ASET-2380 Human PEDF ELISA Kit (AC3791) Quantitative inquiry ASET-1125 Human APH1A ELISA Kit (AC2536) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket